Assessment of Patients with Periorbital Melanosis for Hyperinsulinemia and Insulin Resistance

Overview

Journal Indian Dermatol Online J

Specialty Dermatology

Date 2021 May 7

PMID 33959520

Citations 2

Authors

Devinder M Thappa

Laxmisha Chandrashekar

Medha Rajappa

R Usha

K Muthupandi

Palani S Mohanraj

Malathi Munisamy

Nidhi Singh

Affiliations

Soon will be listed here.

Abstract

Background: Periorbital melanosis (PM) is one of the most common dermatological condition seen in routine practice. Several cutaneous markers such as acanthosis nigricans have been associated with insulin resistance (IR). However, the association of PM with IR needs to be substantiated.

Objective: The objective of the study is to evaluate the association of circulating adipokines and IR with PM.

Materials And Methods: In this cross-sectional study, we recruited 100 patients with PM and 100 age- and gender-matched healthy controls. The serum levels of leptin, adiponectin, fasting glucose, fasting insulin, insulin-like growth factor-1 (IGF-1), homeostatic model assessment of insulin resistance (HOMA-IR), and leptin: adiponectin ratio (L/A ratio) were assayed.

Results: The serum levels of leptin, fasting glucose, fasting insulin, HOMA-IR, L/A ratio were significantly higher in patients with PM as compared to controls. The serum levels of adiponectin were significantly lower in cases as compared to controls. On multivariate regression analysis, leptin, adiponectin, and HOMA-IR were found to be significant, even after adjusting for BMI, blood pressure and LDL and HDL cholesterol.

Conclusion: Our findings suggest that patients with PM have hyperinsulinemia, IR, and elevated L/A ratio. PM as a marker of IR in adults may help in identifying patients early and thus aid in the early prevention and management of the disease.

Citing Articles

Periorbital melanosis and its possible association with insulin resistance and vitamin D deficiency: A pilot case-control study.

Taha S, Salem L, Hassan R, El-Bassiouny M, Hamdy M, El-Mohamdy M J Int Med Res. 2024; 52(8):3000605241270648.

PMID: 39161263 PMC: 11334248. DOI: 10.1177/03000605241270648.

Acanthosis Nigricans: Pointer of Endocrine Entities.

Radu A, Carsote M, Dumitrascu M, Sandru F Diagnostics (Basel). 2022; 12(10).

PMID: 36292208 PMC: 9600076. DOI: 10.3390/diagnostics12102519.

References

Inoue M, Maehata E, Yano M, Taniyama M, Suzuki S . Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes. Metabolism. 2005; 54(3):281-6. DOI: 10.1016/j.metabol.2004.09.006. View

Jung U, Choi M . Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014; 15(4):6184-223. PMC: 4013623. DOI: 10.3390/ijms15046184. View

Brennan A, Mantzoros C . Drug Insight: the role of leptin in human physiology and pathophysiology--emerging clinical applications. Nat Clin Pract Endocrinol Metab. 2006; 2(6):318-27. DOI: 10.1038/ncpendmet0196. View

Verma S, Vasani R, Joshi R, Phiske M, Punjabi P, Toprani T . A descriptive study of facial acanthosis nigricans and its association with body mass index, waist circumference and insulin resistance using HOMA2 IR. Indian Dermatol Online J. 2016; 7(6):498-503. PMC: 5134163. DOI: 10.4103/2229-5178.193898. View

Kahana M, Grossman E, Feinstein A, Ronnen M, Cohen M, Millet M . Skin tags: a cutaneous marker for diabetes mellitus. Acta Derm Venereol. 1987; 67(2):175-7. View

Stefanovic A, Kotur-Stevuljevic J, Spasic S, Bogavac-Stanojevic N, Bujisic N . The influence of obesity on the oxidative stress status and the concentration of leptin in type 2 diabetes mellitus patients. Diabetes Res Clin Pract. 2007; 79(1):156-63. DOI: 10.1016/j.diabres.2007.07.019. View

Uslu S, Kebapci N, Kara M, Bal C . Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus. Exp Ther Med. 2012; 4(1):113-120. PMC: 3460256. DOI: 10.3892/etm.2012.557. View

Patidar P, Ramachandra P, Philip R, Saran S, Agarwal P, Gutch M . Correlation of acanthosis nigricans with insulin resistance, anthropometric, and other metabolic parameters in diabetic Indians. Indian J Endocrinol Metab. 2013; 16(Suppl 2):S436-7. PMC: 3603105. DOI: 10.4103/2230-8210.104122. View

Sarkar R, Das A . Periorbital Hyperpigmentation: What Lies Beneath?. Indian Dermatol Online J. 2018; 9(4):229-230. PMC: 6042190. DOI: 10.4103/idoj.IDOJ_303_17. View

10.

Gonzalez-Saldivar G, Rodriguez-Gutierrez R, Ocampo-Candiani J, Gonzalez-Gonzalez J, Gomez-Flores M . Skin Manifestations of Insulin Resistance: From a Biochemical Stance to a Clinical Diagnosis and Management. Dermatol Ther (Heidelb). 2016; 7(1):37-51. PMC: 5336429. DOI: 10.1007/s13555-016-0160-3. View

11.

Napolitano M, Megna M, Monfrecola G . Insulin resistance and skin diseases. ScientificWorldJournal. 2015; 2015:479354. PMC: 4419263. DOI: 10.1155/2015/479354. View

12.

Ukkola O, Santaniemi M . Adiponectin: a link between excess adiposity and associated comorbidities?. J Mol Med (Berl). 2002; 80(11):696-702. DOI: 10.1007/s00109-002-0378-7. View

13.

Abdella N, Mojiminiyi O, Moussa M, Zaki M, Al Mohammedi H, Al Ozairi E . Plasma leptin concentration in patients with Type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance. Diabet Med. 2005; 22(3):278-85. DOI: 10.1111/j.1464-5491.2004.01405.x. View

14.

Verschoore M, Gupta S, Sharma V, Ortonne J . Determination of Melanin and Haemoglobin in the Skin of Idiopathic Cutaneous Hyperchromia of the Orbital region (ICHOR): A Study of Indian Patients. J Cutan Aesthet Surg. 2012; 5(3):176-82. PMC: 3483573. DOI: 10.4103/0974-2077.101371. View

15.

Spranger J, Kroke A, Mohlig M, Bergmann M, Ristow M, Boeing H . Adiponectin and protection against type 2 diabetes mellitus. Lancet. 2003; 361(9353):226-8. DOI: 10.1016/S0140-6736(03)12255-6. View

16.

Cordain L, Eades M, Eades M . Hyperinsulinemic diseases of civilization: more than just Syndrome X. Comp Biochem Physiol A Mol Integr Physiol. 2003; 136(1):95-112. DOI: 10.1016/s1095-6433(03)00011-4. View

17.

Kotani K, Sakane N, Saiga K, Kurozawa Y . Leptin : adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes : relationship of the index to carotid intima-media thickness. Diabetologia. 2005; 48(12):2684-6. DOI: 10.1007/s00125-005-0015-4. View

18.

Gupta V, Mishra S, Mishra S, Kumar S, Gupta V . Association of Leptin: Adiponectin ratio and metabolic risk markers in postmenopausal women. Immunol Lett. 2018; 196:63-67. DOI: 10.1016/j.imlet.2018.01.008. View

19.

Wannamethee S, Tchernova J, Whincup P, Lowe G, Kelly A, Rumley A . Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis. 2006; 191(2):418-26. DOI: 10.1016/j.atherosclerosis.2006.04.012. View

20.

Asakawa H, Tokunaga K, Kawakami F . Relationship of leptin level with metabolic disorders and hypertension in Japanese type 2 diabetes mellitus patients. J Diabetes Complications. 2001; 15(2):57-62. DOI: 10.1016/s1056-8727(00)00145-8. View